Overexpression of the DEC1 protein induces senescence in vitro and is related to better survival in esophageal squamous cell carcinoma

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Xu, Qing ^a   Ma, Peiqing ^b   Hu, Chenfei ^a   Chen, Lechuang ^a   Xue, Liyan ^b   Wang, Zaozao ^a   Liu, Mei ^a   Zhu, Hongxia ^a   Xu, Ningzhi ^a   Lu, Ning ^b  

^a CANCER HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DIFFERENTIATED EMBRYO CHONDROCYTE EXPRESSED GENE 1 PROTEIN; TRANSCRIPTION FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL AGING; CONTROLLED STUDY; ENZYME ACTIVITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS TUMOR; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR EMBOLISM;

CARCINOMA, SQUAMOUS CELL; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 84864230998     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041862     Document Type: Article

References (57)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
3. Shirakawa Y, Naomoto Y, Kimura M, Kawashima R, Yamatsuji T, et al. (2000) Topological analysis of p21WAF1/CIP1 expression in esophageal squamous dysplasia. Clin Cancer Res 6: 541-550.
4. Xue LY, Hu N, Song YM, Zou SM, Shou JZ, et al. (2006) Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. BMC Cancer 6: 296.
5. Wang GQ, Abnet CC, Shen Q, Lewin KJ, Sun XD, et al. (2005) Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 54: 187-192.
6. Cohen DJ, Ajani J, (2011) An expert opinion on esophageal cancer therapy. Expert Opin Pharmacother 12: 225-239.
7. Ohbu M, Kobayashi N, Okayasu I, (2001) Expression of cell cycle regulatory proteins in the multistep process of oesophageal carcinogenesis: stepwise over-expression of cyclin E and p53, reduction of p21(WAF1/CIP1) and dysregulation of cyclin D1 and p27(KIP1). Histopathology 39: 589-596.
8. Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, et al. (2009) MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 15: 1915-1922.
9. Hayflick L, Moorhead PS, (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
10. Hayflick L, (1965) The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res 37: 614-636.
11. Harley CB, Futcher AB, Greider CW, (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460.
12. Ben-Porath I, Weinberg RA, (2005) The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37: 961-976.
13. Gewirtz DA, Holt SE, Elmore LW, (2008) Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 76: 947-957.
14. Banito A, Rashid ST, Acosta JC, Li S, Pereira CF, et al. (2009) Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev 23: 2134-2139.
15. Mooi WJ, Peeper DS, (2006) Oncogene-induced cell senescence-halting on the road to cancer. N Engl J Med 355: 1037-1046.
16. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS, (2010) The essence of senescence. Genes Dev 24: 2463-2479.
17. Campisi J, d'Adda di Fagagna F, (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740.
18. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724.
19. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, et al. (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665.
20. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730.
21. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, et al. (2005) Tumour biology: senescence in premalignant tumours. Nature 436: 642.
22. Boudjelal M, Taneja R, Matsubara S, Bouillet P, Dolle P, et al. (1997) Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. Genes Dev 11: 2052-2065.
23. Shen M, Kawamoto T, Yan W, Nakamasu K, Tamagami M, et al. (1997) Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. Biochem Biophys Res Commun 236: 294-298.
24. Guillaumond F, Lacoche S, Dulong S, Grechez-Cassiau A, Filipski E, et al. (2008) Altered Stra13 and Dec2 circadian gene expression in hypoxic cells. Biochem Biophys Res Commun 369: 1184-1189.
25. Qian Y, Zhang J, Yan B, Chen X, (2008) DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence. J Biol Chem 283: 2896-2905.
26. Sun H, Taneja R, (2000) Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Proc Natl Acad Sci U S A 97: 4058-4063.
27. Collado M, Serrano M, (2006) The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 6: 472-476.
28. Turley H, Wykoff CC, Troup S, Watson PH, Gatter KC, et al. (2004) The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumours. J Pathol 203: 808-813.
29. Chakrabarti J, Turley H, Campo L, Han C, Harris AL, et al. (2004) The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer 91: 954-958.
30. Zheng Y, Jia Y, Wang Y, Wang M, Li B, et al. (2009) The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in gastric cancer. OMICS 13: 301-306.
31. Li Y, Zhang H, Xie M, Hu M, Ge S, et al. (2002) Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem J 367: 413-422.
32. Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Wykoff CC, et al. (2003) DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol 200: 222-228.
33. Shi XH, Zheng Y, Sun Q, Cui J, Liu QH, et al. (2011) DEC1 nuclear expression: a marker of differentiation grade in hepatocellular carcinoma. World J Gastroenterol 17: 2037-2043.
34. Wang W, Reiser-Erkan C, Michalski CW, Raggi MC, Quan L, et al. (2010) Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Biochem Biophys Res Commun 401: 422-428.
35. Chen X, Zhang W, Gao YF, Su XQ, Zhai ZH, (2002) Senescence-like changes induced by expression of p21(waf1/Cip1) in NIH3T3 cell line. Cell Res 12: 229-233.
36. Umar SB, Fleischer DE, (2008) Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 5: 517-526.
37. Holmes RS, Vaughan TL, (2007) Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 17: 2-9.
38. Chang MS, Lee HS, Lee BL, Kim YT, Lee JS, et al. (2005) Differential protein expression between esophageal squamous cell carcinoma and dysplasia, and prognostic significance of protein markers. Pathol Res Pract 201: 417-425.
39. Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, et al. (2009) Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther 8: 36-46.
40. Vallbohmer D, Lenz HJ, (2006) Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus 19: 425-432.
41. Braig M, Schmitt CA, (2006) Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res 66: 2881-2884.
42. Gorgoulis VG, Halazonetis TD, (2010) Oncogene-induced senescence: the bright and dark side of the response. Curr Opin Cell Biol 22: 816-827.
43. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
44. Prieur A, Peeper DS, (2008) Cellular senescence in vivo: a barrier to tumorigenesis. Curr Opin Cell Biol 20: 150-155.
45. Skinner HD, Sandulache VC, Ow TJ, Meyn RE, Yordy JS, et al. (2012) TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence. Clin Cancer Res 18: 290-300.
46. Campo-Trapero J, Cano-Sanchez J, Palacios-Sanchez B, Llamas-Martinez S, Lo Muzio L, et al. (2008) Cellular senescence in oral cancer and precancer and treatment implications: a review. Acta Oncol 47: 1464-1474.
47. Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, et al. (2007) Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9: 493-505.
48. Ogasawara S, Maesawa C, Tamura G, Satodate R, (1995) Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 55: 891-894.
49. Sakai N, Kajiyama Y, Iwanuma Y, Tomita N, Amano T, et al. (2010) Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions. Dis Esophagus 23: 415-421.
50. Tsai MH, Fang WH, Lin SH, Tzeng ST, Huang CS, et al. (2011) Mapping of genetic deletions on chromosome 3 in colorectal cancer: loss of 3p25-pter is associated with distant metastasis and poor survival. Ann Surg Oncol 18: 2662-2670.
51. Campisi J, (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120: 513-522.
52. Ohtani N, Takahashi A, Mann DJ, Hara E, (2012) Cellular senescence: a double-edged sword in the fight against cancer. Exp Dermatol 21: 1-4.
53. Decottignies A, d'Adda di Fagagna F, (2011) Epigenetic alterations associated with cellular senescence: A barrier against tumorigenesis or a red carpet for cancer? Semin Cancer Biol 21: 360-366.
54. Chandeck C, Mooi WJ, (2010) Oncogene-induced cellular senescence. Adv Anat Pathol 17: 42-48.
55. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847.
56. Han Y, Wei F, Xu X, Cai Y, Chen B, et al. (2002) [Establishment and comparative genomic hybridization analysis of human esophageal carcinomas cell line EC9706]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19: 455-457.
57. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O, (2009) Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4: 1798-1806.